Bristol Myers Squibb (BMY)

[Johnny_C]

Many things have changed for AGN for sure, but that doesn’t mean they are not a target of PFE. PFE has stated they are looking for income now and AGN, while not having BMY sales are pretty close. A lot of AGN self inflicted problems goes away also.

I am still betting BMY, as it makes seems attractive. Great sales, little debt, oncology booming and eliquis. I think most people would guess that the marketing power of PFE has a lot to do with that success. BMY has been seriously floated since BMY pps tanked. First serious rumors were in Febuary. I think it took PFE nearly a year of back and forth before they pulled the trigger on Wyeth.

Lilly is attractive to, like BMY they recently hit 12 month highs. Considering layoffs, massive restructuring and the fact that they do not have the funds to develop all their oncology trials makes that interesting.

I like Celgene, had Receptos before they bought them and that should give Celgene a couple more blockbusters. A friend of mine at BioGen is hoping PFE buys them.

Very light volume today on BMY. I think between now and the 31st we could see some action. If not by year end.

Gonna buy more calls till January at 70 strike.

Good luck